FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1930438273> ?p ?o ?g. }

• W1930438273 endingPage "1038" @default.
• W1930438273 startingPage "1030" @default.
• W1930438273 abstract "Rationale: Pseudomonas aeruginosa infection is a significant cause of morbidity and mortality in patients with cystic fibrosis and is associated with a high economic burden. A recently published comparator trial demonstrated that outcomes in patients with cystic fibrosis with chronic P. aeruginosa infections switched from tobramycin solution for inhalation to aztreonam lysine for inhalation were better than those of patients who continued on tobramycin.Objectives: To compare overall costs of treatment of chronic inhaled tobramycin and aztreonam lysine in patient with cystic fibrosis who have chronic Pseudomonas infection, taking differences in outcomes into account.Methods: A cost-effectiveness analysis with a 3-year time horizon was performed to simulate the economic consequences of either treatment from the perspective of a third party payer in the United States. We extrapolated results from the comparator trial and used data regarding clinical outcomes, quality of life, and costs from published literature and proprietary databases. A Markov structure was used to consider transitions between health states, defined principally by levels of percent predicted of FEV1. Extensive scenario and probabilistic sensitivity analyses were performed.Measurements and Main Results: Use of aztreonam lysine for inhalation was associated with an average cost saving of $41,947 per patient over 3 years, as well as greater quality-adjusted life-years and total life-years. Scenario analyses demonstrated that these findings were robust to changes in key assumptions.Conclusions: It appears, with high likelihood, that the use of aztreonam solution for inhalation is associated with cost savings, an increase in quality-adjusted life-years, and improved clinical outcomes among patients with extensive prior use of tobramycin solution for inhalation who are naive to inhaled aztreonam lysine." @default.
• W1930438273 created "2016-06-24" @default.
• W1930438273 creator A5002707728 @default.
• W1930438273 creator A5018824031 @default.
• W1930438273 creator A5029091133 @default.
• W1930438273 creator A5048181181 @default.
• W1930438273 creator A5054612674 @default.
• W1930438273 date "2015-07-01" @default.
• W1930438273 modified "2023-10-15" @default.
• W1930438273 title "Inhaled Aztreonam Lysine versus Inhaled Tobramycin in Cystic Fibrosis. An Economic Evaluation" @default.
• W1930438273 cites W1576803907 @default.
• W1930438273 cites W1589786989 @default.
• W1930438273 cites W1907761738 @default.
• W1930438273 cites W1971558827 @default.
• W1930438273 cites W1973960158 @default.
• W1930438273 cites W1985262902 @default.
• W1930438273 cites W1993591045 @default.
• W1930438273 cites W2010913334 @default.
• W1930438273 cites W2015368967 @default.
• W1930438273 cites W2028452431 @default.
• W1930438273 cites W2075729934 @default.
• W1930438273 cites W2087137161 @default.
• W1930438273 cites W2092712430 @default.
• W1930438273 cites W2103119913 @default.
• W1930438273 cites W2106250173 @default.
• W1930438273 cites W2110828250 @default.
• W1930438273 cites W2117419474 @default.
• W1930438273 cites W2120806423 @default.
• W1930438273 cites W2124135806 @default.
• W1930438273 cites W2127482479 @default.
• W1930438273 cites W2131236190 @default.
• W1930438273 cites W2134843796 @default.
• W1930438273 cites W2147911744 @default.
• W1930438273 cites W2149001759 @default.
• W1930438273 cites W2149512006 @default.
• W1930438273 cites W2149520619 @default.
• W1930438273 cites W2164654252 @default.
• W1930438273 cites W2167893400 @default.
• W1930438273 cites W2313949504 @default.
• W1930438273 cites W2317332612 @default.
• W1930438273 cites W3122426397 @default.
• W1930438273 cites W3203717762 @default.
• W1930438273 doi "https://doi.org/10.1513/annalsats.201312-453oc" @default.
• W1930438273 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26053185" @default.
• W1930438273 hasPublicationYear "2015" @default.
• W1930438273 type Work @default.
• W1930438273 sameAs 1930438273 @default.
• W1930438273 citedByCount "6" @default.
• W1930438273 countsByYear W19304382732016 @default.
• W1930438273 countsByYear W19304382732019 @default.
• W1930438273 countsByYear W19304382732020 @default.
• W1930438273 countsByYear W19304382732023 @default.
• W1930438273 crossrefType "journal-article" @default.
• W1930438273 hasAuthorship W1930438273A5002707728 @default.
• W1930438273 hasAuthorship W1930438273A5018824031 @default.
• W1930438273 hasAuthorship W1930438273A5029091133 @default.
• W1930438273 hasAuthorship W1930438273A5048181181 @default.
• W1930438273 hasAuthorship W1930438273A5054612674 @default.
• W1930438273 hasConcept C112930515 @default.
• W1930438273 hasConcept C126322002 @default.
• W1930438273 hasConcept C159110408 @default.
• W1930438273 hasConcept C177713679 @default.
• W1930438273 hasConcept C2776938444 @default.
• W1930438273 hasConcept C2776954882 @default.
• W1930438273 hasConcept C2776968632 @default.
• W1930438273 hasConcept C2777637488 @default.
• W1930438273 hasConcept C2778974779 @default.
• W1930438273 hasConcept C2779951463 @default.
• W1930438273 hasConcept C2780416669 @default.
• W1930438273 hasConcept C3019080777 @default.
• W1930438273 hasConcept C42219234 @default.
• W1930438273 hasConcept C523546767 @default.
• W1930438273 hasConcept C54355233 @default.
• W1930438273 hasConcept C64332521 @default.
• W1930438273 hasConcept C71924100 @default.
• W1930438273 hasConcept C86803240 @default.
• W1930438273 hasConceptScore W1930438273C112930515 @default.
• W1930438273 hasConceptScore W1930438273C126322002 @default.
• W1930438273 hasConceptScore W1930438273C159110408 @default.
• W1930438273 hasConceptScore W1930438273C177713679 @default.
• W1930438273 hasConceptScore W1930438273C2776938444 @default.
• W1930438273 hasConceptScore W1930438273C2776954882 @default.
• W1930438273 hasConceptScore W1930438273C2776968632 @default.
• W1930438273 hasConceptScore W1930438273C2777637488 @default.
• W1930438273 hasConceptScore W1930438273C2778974779 @default.
• W1930438273 hasConceptScore W1930438273C2779951463 @default.
• W1930438273 hasConceptScore W1930438273C2780416669 @default.
• W1930438273 hasConceptScore W1930438273C3019080777 @default.
• W1930438273 hasConceptScore W1930438273C42219234 @default.
• W1930438273 hasConceptScore W1930438273C523546767 @default.
• W1930438273 hasConceptScore W1930438273C54355233 @default.
• W1930438273 hasConceptScore W1930438273C64332521 @default.
• W1930438273 hasConceptScore W1930438273C71924100 @default.
• W1930438273 hasConceptScore W1930438273C86803240 @default.
• W1930438273 hasIssue "7" @default.
• W1930438273 hasLocation W19304382731 @default.
• W1930438273 hasLocation W19304382732 @default.
• W1930438273 hasOpenAccess W1930438273 @default.

• next